Skip to Main Content

Paper Details

Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy.
Neuromuscul Disord
2
2023
C-reactive protein, Follistatin, Myostatin, autosomal recessively inherited muscular dystrophy, contractile cross, creatine, dysferlinopathy, follistatin, myostatin, patients, serum creatine kinase, skeletal muscle
Author NameAffiliation
Heather Gordish-DressmanCenter for Translational Science, George Washington University
Kate BushbyThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust
Volker StraubThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust
  • 1 - 3

Datasets

Release 1.2